# Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

> **NCT00393198** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 204 (actual)

## Conditions studied

- Contraception
- Menorrhagia

## Interventions

- **DRUG:** Levonorgestrel (Mirena, BAY86-5028)
- **DRUG:** Cytotec
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00393198
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 204 (ACTUAL)
- **Last updated:** 2014-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00393198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00393198, "Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00393198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*